Barriers and facilitators for therapeutic drug monitoring of beta-lactams and ciprofloxacin in the ICU: a nationwide cross-sectional study

BACKGROUND: Recent studies demonstrated that failure of achieving pharmacodynamic targets of commonly used antibiotics is common in critically ill patients. Therapeutic drug monitoring (TDM) can contribute to optimize the exposure of beta-lactams and ciprofloxacin. While evidence for TDM of these an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ewoldt, Tim M. J., Abdulla, Alan, van den Broek, Puck, Hunfeld, Nicole, Bahmany, Soma, Muller, Anouk E., Gommers, Diederik, Polinder, Suzanne, Endeman, Henrik, Spronk, Inge, Koch, Birgit C. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277596/
https://www.ncbi.nlm.nih.gov/pubmed/35831793
http://dx.doi.org/10.1186/s12879-022-07587-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277596/
https://www.ncbi.nlm.nih.gov/pubmed/35831793
http://dx.doi.org/10.1186/s12879-022-07587-w

Ejemplares similares